SCHEMBL30069736

SCHEMBL30069736

COC(=O)[C@@H]1CN(C(=O)OCc2ccccc2)C(Cc2cccc(C(F)(F)F)c2)=N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 3/20 0.39
S1PR5 Q9H228 3/20 0.39
PDGFRA P16234 1/20 0.39
ENPP2 Q13822 1/20 0.39
ATXN2 Q99700 1/20 0.39
NR4A2 P43354 1/20 0.39
PRKCA P17252 1/20 0.39
PRKCD Q05655 1/20 0.39
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
SIGMAR1 Q99720 2/20 0.38
HTT P42858 2/20 0.38
GRK5 P34947 1/20 0.38
CDK8 P49336 1/20 0.38
PRKD3 O94806 1/20 0.38
CDK7 P50613 1/20 0.38
JAK3 P52333 1/20 0.38
TNK2 Q07912 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26440123 1.00 S1PR1 (0.39) S1PR1S1PR5PDGFRAENPP2ATXN2
SCHEMBL26440334 0.83 SIGMAR1 (0.45) S1PR1S1PR5PDGFRAALDH1A1SMN1; SMN2
SCHEMBL14336170 0.79 CYP3A4 (0.36) SMN1; SMN2HTTHTR2CCYP3A4
SCHEMBL30069842 0.74 DRD4 (0.40) MEN1KMT2ASIGMAR1HTTHTR2C
SCHEMBL26440261 0.74 DRD4 (0.40) MEN1KMT2ASIGMAR1HTTHTR2C
SCHEMBL4795172 0.71 SCD (0.43) NR4A2ALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL30069894 0.71 SCD (0.43) NR4A2ALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL30069844 0.71 HTT (0.42) NR4A2ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL26440108 0.71 HTT (0.42) NR4A2ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL26440184 0.71 POLB (0.43) NR4A2SMN1; SMN2KMT2AHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131899-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL THERAPEUTICS, INC. (US) 2023-04-27 US disclosed
EP-4087560-A2 INHIBITORS OF MICROBIALLY INDUCED AMYLOID Axial Therapeutics, Inc. (US) 2022-11-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131899-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID SNCA, PARK7, PRNP S1PR1 3668/4885S1PR5 4025/4885PDGFRA 3224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.